{
    "title": "Gilead's new drug keeps 56 pct of lymphoma trial patients alive",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5164767/Gileads-new-drug-keeps-56-pct-lymphoma-trial-patients-alive.html",
    "date": "2017-12-10",
    "keywords": [
        "cancer",
        "therapy",
        "yescarta",
        "remission",
        "beasley",
        "trial",
        "blood",
        "year",
        "treatment",
        "percent",
        "protein",
        "gilead",
        "combination",
        "dec",
        "half",
        "form",
        "study",
        "food",
        "drug",
        "administration",
        "bcell",
        "lymphoma",
        "part",
        "class",
        "antigen",
        "receptor",
        "tcell",
        "bodys",
        "immune",
        "median",
        "research",
        "orlando",
        "meeting",
        "society",
        "hematology",
        "locke",
        "vice",
        "chair",
        "department",
        "marrow",
        "transplant",
        "immunotherapy",
        "center",
        "tampa",
        "florida",
        "investigator",
        "work",
        "cell",
        "tumor",
        "tissue",
        "cd19",
        "evidence",
        "pdl1",
        "antibody",
        "ash",
        "price",
        "buyout",
        "deena",
        "zieminski"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}